Scroll
To Top
Loading Events

« All Events

  • This event has passed.

MitoAction March Expert Series – MELAS Spectrum Disorders and Sonlicromanol: Progress Update

March 18 @ 12:00 pm - 1:00 pm

Join MitoAction and Dr. Jan Smeitink, CEO of Khondrion, for our March Expert Series presentation titled MELAS Spectrum Disorders and Sonlicromanol: Progress Update . MELAS spectrum (m.3243A>G) disorders belong to the most frequently encountered group of primary mitochondrial diseases with an unmet medical need for treatment development. Following an introduction of the clinical disease spectrum, Dr. Smeitink will discuss the development and state-of-art of Khondrion’s lead product, sonlicromanol. Register here: https://www.mitoaction.org/events/march-expert-series-melas-spectrum-disorders-and-sonlicromanol-progress-update/

Organizer

MitoAction

Other

Disease
MELAS Spectrum Disorders